Skip to content

NO HEADACHE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

NO HEADACHE

BE 0430.126.506
NACE 21.100, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€2,610
2024 · €9,134-€6,524
Equity
€191,893
2024 · €189,284+€2,610
Cash
€739
2024 · €603+€137
Balance sheet total
€261,728
2024 · €254,474+€7,254

Largest movements

2024 to 2025
Assets
  • Receivables after one year +€20,792

    up €20,792 (+9.2%), from €224,940 to €245,733

  • Intangible fixed assets -€14,791

    down €14,791 (-76.1%), from €19,436 to €4,644

Equity and liabilities
  • Other debts +€4,500

    up €4,500 (+45.9%), from €9,800 to €14,300

  • Short-term financial debts -€4,205

    no longer reported in 2025 (was €4,205)

  • Trade debts +€3,849

    up €3,849 (+145%), from €2,663 to €6,512

Income statement
  • Gross operating margin -€9,952

    down €9,952 (-48.9%), from €20,358 to €10,407

  • Depreciation -€2,204

    down €2,204 (-13.0%), from €16,995 to €14,791

  • Financial income +€908

    up €908 (+10.6%), from €8,589 to €9,497

  • Other operating charges -€578

    down €578 (-26.5%), from €2,177 to €1,600

  • Financial charges +€262

    up €262 (+40.9%), from €641 to €903

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €9,134
Gross operating margin -€9,952
Depreciation +€2,204
Other operating charges +€578
Financial income +€908
Financial charges -€262
Result 2025 €2,610
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€4,341
Investment €0
Financing -€4,205
Cash 2024 €603
Net result for the year +€2,610
Depreciation +€14,791
Receivables after one year -€20,792
Receivables within one year -€1,116
Trade debts +€3,849
Tax, wage and social debts +€500
Other debts +€4,500
Short-term financial debts -€4,205
Cash 2025 €739
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €254,474 €261,728 +€7,254 +2.9%
Fixed assets 21/28 €19,436 €4,644 -€14,791 -76.1%
Intangible fixed assets 21 €19,436 €4,644 -€14,791 -76.1%
Current assets 29/58 €235,039 €257,084 +€22,045 +9.4%
Amounts receivable after more than one year 29 €224,940 €245,733 +€20,792 +9.2%
Other amounts receivable 291 €224,940 €245,733 +€20,792 +9.2%
Stocks and contracts in progress 3 €4,800 €4,800 = 0.0%
Stocks 30/36 €4,800 €4,800 = 0.0%
Amounts receivable within one year 40/41 €4,696 €5,812 +€1,116 +23.8%
Trade receivables 40 €4,696 €5,812 +€1,116 +23.8%
Cash at bank and in hand 54/58 €603 €739 +€137 +22.7%
Total equity and liabilities 10/49 €254,474 €261,728 +€7,254 +2.9%
Equity 10/15 €189,284 €191,893 +€2,610 +1.4%
Contributions 10/11 €74,368 €74,368 = 0.0%
Capital 10 €74,368 €74,368 = 0.0%
Issued capital 100 €74,368 €74,368 = 0.0%
Reserves 13 €7,437 €7,437 = 0.0%
Non-distributable reserves 130/1 €7,437 €7,437 = 0.0%
Legal reserve 130 €7,437 €7,437 = 0.0%
Profit (loss) carried forward 14 €107,479 €110,088 +€2,610 +2.4%
Amounts payable 17/49 €65,191 €69,835 +€4,644 +7.1%
Amounts payable within one year 42/48 €16,692 €21,336 +€4,644 +27.8%
Financial debts 43 €4,205 - -€4,205
Credit institutions 430/8 €4,205 - -€4,205
Trade debts 44 €2,663 €6,512 +€3,849 +145%
Suppliers 440/4 €2,663 €6,512 +€3,849 +145%
Taxes, remuneration and social security 45 €25 €525 +€500 +2,027%
Taxes 450/3 €25 €525 +€500 +2,027%
Other amounts payable 47/48 €9,800 €14,300 +€4,500 +45.9%
Accrued charges and deferred income 492/3 €48,499 €48,499 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,995 €14,791 -€2,204 -13.0%
Other operating charges 640/8 €2,177 €1,600 -€578 -26.5%
Gross operating margin 9900 €20,358 €10,407 -€9,952 -48.9%
Operating profit (loss) 9901 €1,186 -€5,984 -€7,170
Financial income 75/76B €8,589 €9,497 +€908 +10.6%
Recurring financial income 75 €8,589 €9,497 +€908 +10.6%
Financial charges 65/66B €641 €903 +€262 +40.9%
Recurring financial charges 65 €641 €903 +€262 +40.9%
Profit (loss) for the period before taxes 9903 €9,134 €2,610 -€6,524 -71.4%
Profit (loss) for the period 9904 €9,134 €2,610 -€6,524 -71.4%
Profit (loss) for the period to be appropriated 9905 €9,134 €2,610 -€6,524 -71.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.